Actively Recruiting

Phase Not Applicable
Age: 50Years - 70Years
All Genders
NCT07237412

Neurofeedback-based Visual Restoration Therapy

Led by Adrian Guggisberg · Updated on 2026-04-29

14

Participants Needed

2

Research Sites

127 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Visual field defects are a common consequence of acquired brain injuries and affect people of all ages. These vision problems make everyday life more difficult-for example, when reading, driving, or moving around safely. However, there is currently no effective therapy to improve visual field defects. Previous training methods have focused on maximizing brain activity during a task. However, new findings show that the best performance is achieved when the brain is already in a state of high communication before the task. Our research shows that people can learn to increase communication between brain regions through neurofeedback. Studies have shown that neurofeedback can help people after a stroke: it improves the coordination of brain areas that are important for movement, thereby helping to increase mobility. Building on these findings, this study investigates whether EEG neurofeedback can support the visual centers in the brain to improve vision in patients with chronic visual field defects. The main objective of the study is to evaluate the effectiveness of neurofeedback in improving visual field defects. More specifically, the investigators are investigating the development of visual ability (expansion of the visual field, contrast sensitivity).

CONDITIONS

Official Title

Neurofeedback-based Visual Restoration Therapy

Who Can Participate

Age: 50Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Chronic, stable homonymous visual field defects (lateral quadranopsia or hemianopsia)
  • Stroke occurred 12 months or more before enrollment
  • Age between 50 and 70 years
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Inability to concentrate during long treatment sessions
  • Eye disease affecting visual field or visual acuity
  • Presence of non-MRI safe metal in the body
  • New stroke during the study period
  • Hemispatial neglect

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Inselspital

Bern, Canton of Bern, Switzerland, 3010

Actively Recruiting

2

Division of Neurorehabilitation, University Hospital of Geneva

Geneva, Canton of Geneva, Switzerland, 1202

Not Yet Recruiting

Loading map...

Research Team

A

Adrian Guggisberg, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Neurofeedback-based Visual Restoration Therapy | DecenTrialz